⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8853469 | 0.76 | CHRM2 (0.30) | — | |
| SCHEMBL6983665 | 0.72 | LMNA (0.33) | — | |
| SCHEMBL110853 | 0.69 | LMNA (0.30) | — | |
| SCHEMBL15685824 | 0.69 | LMNA (0.30) | — | |
| SCHEMBL28264411 | 0.67 | CHRM2 (0.30) | — | |
| SCHEMBL6043728 | 0.67 | CHRM2 (0.30) | — | |
| SCHEMBL28833051 | 0.67 | CA1 (0.36) | — | |
| Ammonia Solution, Strong SCHEMBL1289838 | 0.66 | — | — | |
| SCHEMBL465317 | 0.66 | TDP1 (0.31) | — | |
| SCHEMBL4756710 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1987037-A2 | FUSED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007097470-A2 | FUSED NITROGEN- COMPRISING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-08-30 | — | — | WO | disclosed |